20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with miconazole in 9 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (miconazole) | Trials (miconazole) | Recent Studies (post-2010) (miconazole) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 2,309 | 238 | 476 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | miconazole (IC50) |
|---|---|---|---|
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | 6.5 | |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.4 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 5.314 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Cytochrome P450 1A2 | Mus musculus (house mouse) | 4.55 | |
| Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | 4.55 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 4.55 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.16 | |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.8 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.939 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 4.336 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.197 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.4938 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.966 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.811 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.32 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 3.971 | |
| Aromatase | Homo sapiens (human) | 0.6 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.2 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 5.482 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 3.7 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 7.089 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.598 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 3.154 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 7.8 | |
| Substance-K receptor | Homo sapiens (human) | 4.839 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 6.247 | |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 5.8 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.939 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.263 | |
| Histamine H2 receptor | Homo sapiens (human) | 6.75 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.046 | |
| Substance-P receptor | Homo sapiens (human) | 6.813 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.907 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 5.314 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.778 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.008 | |
| Mu-type opioid receptor | Homo sapiens (human) | 6.059 | |
| D(3) dopamine receptor | Homo sapiens (human) | 3.199 | |
| Delta-type opioid receptor | Homo sapiens (human) | 3.387 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 6.594 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 5.545 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Cholinesterase | Equus caballus (horse) | 5.55 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.701 | |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.2 | |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imig, JD; Kaldunski, M; Ortiz de Montellano, PR; Roman, RJ; Sui, Z; Zou, AP | 1 |
| Imig, JD; Ortiz de Montellano, PR; Roman, RJ; Sui, Z; Zou, AP | 1 |
| Benzoni, D; Bernard, N; Messer-Létienne, I; Roman, RJ; Sassard, J | 1 |
| Oyekan, AO | 1 |
| Abe, M; Arima, S; Chiba, Y; Endo, Y; Ito, O; Ito, S; Kohagura, K; Omata, K | 1 |
| Campbell, WB; Endsley, MP; Falck, JR; Gross, ER; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
| Caron, N; Declèves, AE; El Hajjam, A; Falck, JR; Joly, E; Kramp, R | 1 |
| Metea, MR; Newman, EA | 1 |
| Bolognesi, M; Gaiani, S; Gatta, A; Jiang, H; McGiff, JC; Sacerdoti, D | 1 |
9 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and miconazole
| Article | Year |
|---|---|
Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow.
Topics: Animals; Arachidonic Acid; Cytochrome P-450 Enzyme System; Fatty Acids, Unsaturated; Homeostasis; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney; Kidney Cortex; Kidney Medulla; Kinetics; Male; Miconazole; Microcirculation; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation | 1994 |
Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Arterioles; Cytochrome P-450 Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney; Kidney Cortex; Miconazole; Microsomes; Muscle, Smooth, Vascular; Oxazines; Perfusion; Rats; Rats, Sprague-Dawley; Renal Circulation | 1994 |
20-Hydroxyeicosatetraenoic acid and renal function in Lyon hypertensive rats.
Topics: Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fatty Acids, Unsaturated; Heptanoic Acids; Hydroxyeicosatetraenoic Acids; Hypertension; In Vitro Techniques; Kidney; Male; Miconazole; Organ Size; Oxygenases; Rats; Receptors, Thromboxane; Renal Circulation; Systole; Vascular Resistance; Vasodilation | 1999 |
Cytochrome p450-dependent metabolites of arachidonic acid and renal function in the rat.
Topics: Animals; Antifungal Agents; Arachidonic Acid; Blood Pressure; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Homeostasis; Hydroxyeicosatetraenoic Acids; Kidney; Kidney Function Tests; Male; Miconazole; Natriuresis; Rats; Rats, Sprague-Dawley; Renal Circulation; Urodynamics | 2000 |
Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arachidonic Acid; Arterioles; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Male; Miconazole; Norepinephrine; Rabbits; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Circulation; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Miconazole; Microsomes; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones | 2004 |
Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases.
Topics: Animals; Arachidonic Acid; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hemodynamics; Hydroxyeicosatetraenoic Acids; Indomethacin; Kidney; Male; Miconazole; Rats; Rats, Wistar; Renal Circulation; Vasodilation | 2004 |
Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling.
Topics: 8,11,14-Eicosatrienoic Acid; Adenosine Triphosphate; Amidines; Animals; Arterioles; Calcium Signaling; Caproates; Cyclic N-Oxides; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Eye Proteins; Hydrazines; Hydroxyeicosatetraenoic Acids; Imidazoles; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Miconazole; Neuroglia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Photolysis; Proadifen; Purinergic Antagonists; Rats; Rats, Long-Evans; Retinal Vessels; Signal Transduction; Vasoconstriction; Vasodilation; Vasomotor System | 2006 |
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Carbon Tetrachloride; Cytochrome P-450 Enzyme System; Endothelin-1; Hepatic Veins; Hydroxyeicosatetraenoic Acids; Hypertension, Portal; Infusion Pumps; Liver; Liver Cirrhosis, Experimental; Male; Miconazole; Organ Culture Techniques; Oxidoreductases; Phenylephrine; Portal Pressure; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasodilation | 2011 |